White House Government Agencies

  • Feb 16- The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc's, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can't be surgically removed. The approval was based on a trial testing on 713 patients whose cancer had not progressed after chemotherapy and radiation.

  • data@ NEW YORK, Feb 16- Speculators' net short bets on the U.S. dollar in the latest week shrank to a six-week low, according to calculations by Reuters and Commodity Futures Trading Commission data released on Friday. In a wider measure of dollar positioning that includes net contracts on the New Zealand dollar, Mexican peso, Brazilian real and Russian ruble, the U.S....

  • NEW YORK, Feb 16- Speculators' net short dollar bets shrank to a six-week low, in the latest week, according to calculations by Reuters and Commodity Futures Trading Commission data released on Friday. The value of the net short dollar positions, derived from net positions of International Monetary Market speculators in the yen, euro, British pound, Swiss franc and...

  • Feb 16- The world's largest plane maker Boeing Co said on Friday the U.S. Federal Aviation Administration had officially certified its 737 MAX-9 aircraft for commercial service. Keith Leverkuhn, 737 general manager, said on Wednesday he expected the certification "within a matter of days-weeks." Boeing said it was in the final stages of preparing the aircraft,...

  • *FDA flags safety concerns with ingredient, manufacturing. *Analyst estimated peak sales of $200 mln. Feb 16- The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream to treat erectile dysfunction, for the second time in a decade, sending the company's shares down more than 70 percent before the opening bell.

  • Feb 16- The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream treatment for erectile dysfunction, for the second time in a decade. The FDA flagged certain safety concerns related to an ingredient in the drug and identified deficiencies in its chemistry and manufacturing, the company said.

  • Feb 16- Apricus Biosciences Inc said on Friday the U.S. Food and Drug Administration declined to approve Vitaros, a cream-based treatment for erectile dysfunction, in its present form.

  • TOKYO— Bank of Japan Gov. The effort has helped Japan attain eight straight quarters of growth in the longest expansion since the country's economic bubble collapsed nearly 30 years ago. In that sense Japan's monetary policies contrast with those in Europe and the U.S., where the Federal Reserve has gradually begun to raise interest rates.

  • HONOLULU— Critics are blasting the U.S. Environmental Protection Agency for dramatically lowering a fine on agribusiness company Syngenta for violations of pesticide regulations. Syngenta, under a settlement announced this week, will pay $150,000 for improperly using the pesticide chlorpyrifos at a seed corn field in Hawaii in 2016 and 2017.

  • WASHINGTON, Feb 15- Amazon.com Inc will pay a roughly $1.2 million penalty to settle nearly 4,000 alleged violations of U.S. law in a move aimed at preventing harmful exposure to pesticides through illegal sales, the U.S. Environmental Protection Agency said on Thursday.

  • WASHINGTON— Colorado's Republican U.S. senator said Thursday he will stop blocking nominees for some Justice Department jobs, saying he is encouraged by recent conversations with federal officials about the treatment of the state's marijuana industry, despite the Trump administration's tougher stance. Attorney General Jeff Sessions rescinded...

  • President Donald Trump's nominee for a top State Department energy position said on Thursday he would oppose Russia's proposed natural gas pipeline under the Baltic Sea to Germany- the Nord Stream 2.. "The United States' position, it is my understanding, is to strongly oppose that pipeline," Francis Fannon, who has been nominated Assistant Secretary of State for...

  • Venture capitalist Peter Thiel of the Founders Fund and other technology executives and leaders attend the inaugural meeting of the American Technology Council in the Indian Treaty Room at the Eisenhower Executive Office Building next door to the White House June 19, 2017 in Washington, DC.

    Facebook, where Thiel sits on the board, has been at the center of calls for greater regulation in recent months.

  • David Shulkin, Under Secretary for the US Department of Veterans Affairs.

    The VA inspector general found Shulkin improperly accepted Wimbledon tickets and taxpayer-funded airfare for his wife, USA TODAY reports.

  • WASHINGTON— U.S. factory output was unchanged in January for the second straight month after three months of healthy gains. The Federal Reserve said Thursday that production fell in wood products, aircraft and a category including concrete and glass. Yet factories also cranked out more cars and computers.

  • FBI Director Christopher Wray (L) and CIA Director Mike Pompeo (2nd L) testify on worldwide threats during a Senate Intelligence Committee hearing on Capitol Hill in Washington, DC, February 13, 2018.

    Republicans are resisting requests by Democrats for U.S. intelligence chiefs to present their annual global threat report to a congressional panel.

  • Federal Communications Commission Chairman Ajit Pai listens during a commission meeting December 14, 2017 in Washington, DC. The FCC is scheduled to vote on a proposal to repeal net-neutrality.

    The inquiry puts a spotlight on Mr. Pai’s decisions and may also him to answer questions that he has so far avoided addressing in public, NYT reports.

  • General view of the US Embassy in Cuba after the US government pulled more than half of its diplomatic personnel out of Cuba who suffered health problems due to an alleged sonic attack on September 29, 2017 in Havana, Cuba.

    U.S. government personnel serving in Cuba appear to have "widespread" neurological damage, say doctors working for the State Department.

  • Feb 14- The U.S. Food and Drug Administration on Wednesday approved Johnson& Johnson's Erleada for use in prostate cancer patients whose disease has not spread but continues to grow despite hormone therapy. The drug is the first FDA- approved treatment for non-metastatic, castration-resistant prostate cancer, the regulator said. The list price of Erleada is...